Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Erika Carmel-TechXTAE:ERKA 36 Buyback Yield % is 0.00 as of Aug. 03, 2026. GuruFocus rates XTAE:ERKA with a GF Score™ of 36/100 and a GF Value™ of ₪0.55 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 346 Medical Devices & Instruments companies, Erika Carmel-Tech ranks worse than 289017.05% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Erika Carmel-Tech's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ERKA vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Erika Carmel-Tech's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Erika Carmel-Tech Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Erika Carmel-Tech's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Erika Carmel-Tech's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Erika Carmel-Tech (XTAE:ERKA) has a Buyback Yield % of 0.00 as of Aug. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Erika Carmel-Tech and its competitors. According to the industry distribution chart, Erika Carmel-Tech ranks #999999 out of 346 companies in the Medical Devices & Instruments industry.
Is Erika Carmel-Tech's Buyback Yield % too high?
Erika Carmel-Tech's current Buyback Yield % is 0.00. Based on the distribution chart, Erika Carmel-Tech ranks #999999 out of 346 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Erika Carmel-Tech has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Erika Carmel-Tech ranks #999999 out of 346 companies for Buyback Yield %. This places Erika Carmel-Tech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Erika Carmel-Tech and its competitors. Erika Carmel-Tech's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.49 — trading 10.2% below its estimated fair value. The current Buyback Yield % is 0.00. Erika Carmel-Tech's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current Buyback Yield % is 0.00 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?
Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued.
The current stock price of ₪0.49 is trading 10.2% below its estimated GF Value™ of ₪0.55.
GuruFocus considers Erika Carmel-Tech to be Modestly Undervalued.
Key valuation signals for XTAE:ERKA:
Buyback Yield %: 0.00
GF Value™: ₪0.55 vs. price of ₪0.49 (10.2% below fair value)
No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
36GF Score
Get the complete analysis for XTAE:ERKA
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ERKA has been successfully added to your 
